Pivotal bioVenture Partners Investment Advisor
Latest statistics and disclosures from Pivotal bioVenture Partners Investment Advisor's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Karuna Therapeutics Ord, PCVX, OCS, INZY, RLYB, and represent 90.37% of Pivotal bioVenture Partners Investment Advisor's stock portfolio.
- Added to shares of these 4 stocks: Gracell Biotechnologies, INZY, Karuna Therapeutics Ord, IOBT.
- Started 2 new stock positions in IOBT, Gracell Biotechnologies.
- Reduced shares in these 1 stock: OCS.
- Pivotal bioVenture Partners Investment Advisor was a net buyer of stock by $9.4M.
- Pivotal bioVenture Partners Investment Advisor has $251M in assets under management (AUM), dropping by -17.35%.
- Central Index Key (CIK): 0001844645
Tip: Access up to 7 years of quarterly data
Positions held by Pivotal bioVenture Partners Investment Advisor consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Pivotal bioVenture Partners Investment Advisor
Pivotal bioVenture Partners Investment Advisor holds 13 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Karuna Therapeutics Ord | 53.8 | $135M | 797k | 169.09 |
|
|
| Vaxcyte (PCVX) | 16.1 | $40M | 793k | 50.98 |
|
|
| Oculis Holding Ordinary Shares (OCS) | 9.7 | $24M | -6% | 2.2M | 11.00 |
|
| Inozyme Pharma (INZY) | 7.5 | $19M | +22% | 4.5M | 4.20 |
|
| Rallybio Corp (RLYB) | 3.2 | $8.1M | 2.4M | 3.37 |
|
|
| Arcutis Biotherapeutics (ARQT) | 2.3 | $5.9M | 1.1M | 5.31 |
|
|
| Fusion Pharmaceuticals (FUSN) | 1.6 | $4.1M | 1.6M | 2.60 |
|
|
| Gracell Biotechnologies Sponsored Ads | 1.6 | $4.0M | NEW | 1.4M | 2.88 |
|
| Exscientia Ads (EXAI) | 1.4 | $3.5M | 771k | 4.52 |
|
|
| Vigil Neuroscience (VIGL) | 1.2 | $3.0M | 561k | 5.39 |
|
|
| Bolt Biotherapeutics (BOLT) | 0.8 | $2.0M | 1.9M | 1.04 |
|
|
| Io Biotech (IOBT) | 0.5 | $1.2M | NEW | 864k | 1.41 |
|
| Aligos Therapeutics (ALGS) | 0.2 | $555k | 743k | 0.75 |
|
Past Filings by Pivotal bioVenture Partners Investment Advisor
SEC 13F filings are viewable for Pivotal bioVenture Partners Investment Advisor going back to 2020
- Pivotal bioVenture Partners Investment Advisor 2023 Q3 filed Nov. 13, 2023
- Pivotal bioVenture Partners Investment Advisor 2023 Q2 filed Aug. 11, 2023
- Pivotal bioVenture Partners Investment Advisor 2023 Q1 filed May 12, 2023
- Pivotal bioVenture Partners Investment Advisor 2022 Q4 filed Feb. 13, 2023
- Pivotal bioVenture Partners Investment Advisor 2022 Q3 filed Nov. 10, 2022
- Pivotal bioVenture Partners Investment Advisor 2022 Q2 filed Aug. 12, 2022
- Pivotal bioVenture Partners Investment Advisor 2022 Q1 filed May 13, 2022
- Pivotal bioVenture Partners Investment Advisor 2021 Q4 filed Feb. 14, 2022
- Pivotal bioVenture Partners Investment Advisor 2021 Q3 filed Nov. 15, 2021
- Pivotal bioVenture Partners Investment Advisor 2021 Q2 filed Aug. 16, 2021
- Pivotal bioVenture Partners Investment Advisor 2021 Q1 filed May 14, 2021
- Pivotal bioVenture Partners Investment Advisor 2020 Q4 filed Feb. 9, 2021